Meningioma UK is hosting an event in Cambridge to increase awareness of a life threatening tumour.Set up in 1999 as a patient support group by Caroline Rutgers and Ella Pybus, Meningioma provides national support and information for meningioma patients.
Meningioma tumours are more common in older people and in women, although they may occur in men and in young people too. The tumour grows in the tissues covering the brain. They are most often found in the forebrain or hindbrain.
The latest Cancer Research UK statistics show that between a quarter and a third (25- 33 per cent) of all primary brain tumours in adults is a meningioma. Meningiomas do not spread. Ninety percent of meningiomas are benign (non-cancerous), 6% are atypical, and 2% are malignant.
Meningioma tumours of the brain or spinal cord are responsible for approximately 33 per cent of all primary CNS tumours. While meningiomas are generally easy to treat, some are not.
Cambridge Brain Tumour Patients Information Conference & Meningioma Awareness Day (MAD) is being hosted at Cambridge Cancer Support Centre, Scotsdales Garden Centre, Great Shelford, Cambridge on March 17. There is a £25 fee which includes lunch and refreshments. To book for the event see: http://mgmconf2012.eventbrite.co.uk Speakers include: Dr Sarah Jefferies, Mr Ramez Kirollos, Dr Richard Mannion, Dr Jem Rashbass, Dr Colin Watts and others on topics such as Neuroscience, Surgery, Oncology, NHS reforms, Quality of life.
Meningioma UK maintains links with other brain tumour organisations including Cancer 52 (for rare tumours), and the Cancer Campaign Group CCG, Brain Tumour UK, The IBTA (International Brain Tumour Alliance), and AMNET for Acoustic Neuroma network. We are actively involved in advocating more research funding and better care for all brain tumour patients and carers. The national support group set up and run by meningioma patients for everyone affected by a meningeal tumour(s) of the brain or spinal cord.
To donate visit: http://www.meningiomauk.org/17.html
• PHOTOGRAPH SHOWS: A contrast enhanced CT scan of the brain, demonstrating the appearance of a Meningioma.